Dr. John Mandrola shares a great update on the latest info regarding dabigatran (Pradaxa, Pradax). Dr. Mandrola not only treats atrial fibrillation patients, but he has also experienced afib himself. I have become an AF-doctor. That means my most exciting aspect of medicine is terminating AF with watts delivered through a catheter. “Got it.” In …
Read More
We have received word of a study at Vanderbilt University to determine if fish oil supplements decrease afib. Below is the info they sent in case you are interested in participating and are in the Nashville, Tennessee area… Recruiting Patients with Atrial Fibrillation We are recruiting patients with atrial fibrillation to participate in an NIH-sponsored …
Read More
Our good friends at the Atrial Fibrillation Association (in the UK) have just sent out the message below. Please help them win funds to continue raising awareness of atrial fibrillation. Atrial Fibrillation Association (AFA) is calling on people to vote to help it secure funds for its vital projects to improve the lives of people …
Read More
watchLAB is conducting a market research study by phone with Atrial Fibrillation patients throughout the US who have had both chemical (IV) and electrical cardioversions, preferably in the past 2 years. See below for the definitions they have supplied to help you determine if you are qualified to participate. If you qualify, you will be …
Read More
Mellanie True Hills, founder of StopAfib.org, recently spoke at the Fourth Annual Western Atrial Fibrillation Symposium. Many of her remarks to this medical conference are summarized in an article just published in EP Lab Digest. You may wish to share it with family and friends who need to understand what it's like to live with …
Read More
In this video interview at Boston Atrial Fibrillation Symposium, Dr. Pierre Jais, of the University of Bordeaux (Bordeaux, France), clarifies his group's recently-published long-term catheter ablation results. These results were called "sobering" in the media, but Dr. Jais sees them as encouraging. Pierre Jais, MD, is Professor of Cardiology at …
Read More
In this video interview, Dr. Keith Ferdinand, Professor at Emory University and Chief Science Officer of the Association of Black Cardiologists, talked about minority health. He focused especially on heart disease and atrial fibrillation among blacks and African Americans. He addressed the conundrum of why blacks appear to have less …
Read More
Do you know what impact atrial fibrillation has on your state? Check out the new AF Stat report, AFib in America: State Impact Reports, to identify key state-by-state statistics, resources and state health department programs related to the burden of atrial fibrillation. To learn more, see: New Analysis Illustrates the Hidden Burden of Atrial Fibrillation …
Read More
In this video, Dr. Keith Ferdinand, Chief Science Officer of the Association of Black Cardiologists, talked about heart disease and atrial fibrillation among minorities, especially blacks and African Americans. He talked about why blacks appear to have less afib than whites, and what blacks should be doing to prevent AF and heart disease. Watch the …
Read More
In this video, Dr. Matthew Reynolds, of the Harvard Clinical Research Institute, discussed his quality of life findings from use of catheter ablation and antiarrhythmic drugs for treatment of atrial fibrillation. He analyzed quality of life data that was collected as part of the THERMOCOOL catheter trial in which catheter ablation was found to be …
Read More